Dashboard
Weak Long Term Fundamental Strength as the company has not declared results in the last 6 months
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.01 times
- The company has been able to generate a Return on Equity (avg) of 1.85% signifying low profitability per unit of shareholders funds
The company has declared negative results for the last 5 consecutive quarters
Risky - Negative Book Value
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Transport Services
USD 7 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-14.26
128.10%
-0.07
Total Returns (Price + Dividend) 
ModivCare, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is ModivCare, Inc. technically bullish or bearish?
As of 10 September 2025, the technical trend for ModivCare, Inc. has changed from mildly bearish to bearish. The current stance is bearish with a weak strength indicated by the weekly MACD being bearish, daily moving averages also bearish, and Bollinger Bands signaling bearish conditions across both weekly and monthly time frames. The KST is mildly bearish on the weekly and bearish on the monthly. The stock has significantly underperformed against the S&P 500, with a year-to-date return of -97.89% compared to the S&P's 12.22%....
Read MoreIs ModivCare, Inc. overvalued or undervalued?
As of 25 February 2022, the valuation grade for ModivCare, Inc. changed from expensive to risky, indicating a significant shift in its perceived value. The company appears to be overvalued given its financial metrics, particularly with a Price to Book Value of -0.90 and an EV to EBIT ratio of 115.84, which suggests that the market is pricing the company excessively high relative to its earnings potential. Additionally, the EV to EBITDA ratio stands at 10.28, further reinforcing the notion of overvaluation. In comparison to its peers, ModivCare, Inc. has a less favorable EV to EBITDA ratio than Seacor Marine Holdings, Inc., which has an EV to EBITDA of 27.0942, highlighting a stark contrast in valuation. The company's recent stock performance has been dismal, with a year-to-date return of -97.89% compared to the S&P 500's positive return of 12.22%, underscoring the challenges it faces in the market. Overall...
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 51 Schemes (42.15%)
Held by 76 Foreign Institutions (12.63%)
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
YoY Growth in quarter ended Mar 2025 is -4.94% vs 3.35% in Mar 2024
YoY Growth in quarter ended Mar 2025 is -126.01% vs -457.50% in Mar 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 1.32% vs 9.85% in Dec 2023
YoY Growth in year ended Dec 2024 is 1.56% vs -543.08% in Dec 2023






